EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Metabolic Reprogramming and Cell Interaction in Atherosclerosis: From Molecular Mechanisms to Therapeutic Strategies

Yu-Xin Liu, Feng-Ming Guo, Wen-Jun Qiu, Yi-Peng Gao, Xue-Yu Han, Bo Shen iD

Journal of Cardiovascular Development and Disease · 28.09.2025 · 12 (10) · 384

DOI: 10.3390/jcdd12100384 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Cardiovascular Development and Disease, online erschienen am 28.09.2025. Verfasst von Yu-Xin Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, China. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 120 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hubei Provincial Key Research and Development Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atherosclerosis is a complex systemic inflammatory metabolic disease, which originates from endothelial dysfunction and progresses through plaque formation involving vascular smooth muscle cells (VSMCs) and macrophage uptake of modified low-density lipoprotein (LDL). These processes lead to vascular stenosis, plaque rupture, and potentially sudden death. Metabolic dysregulation and cellular remodeling are fundamental to the pathogenesis of atherosclerosis. In this review, we summarize recent advances in the metabolic reprogramming of major cell types (including endothelial cells, VSMCs, and macrophages) during atherosclerosis progression. Furthermore, we discuss the crosstalk among these cells mediated by such metabolic alterations. Finally, we highlight the implications of metabolic reprogramming for targeted therapeutic strategies, offering insights for precision intervention in aortic atherosclerosis.

Schlagwörter

Stichwörter der Autor:innen

atherosclerosisendothelial cellglucose and lipid metabolismmacrophagepharmacologic treatmentvascular smooth muscle cell

Autor:innen und Institutionen

  • Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, China.
  • Hubei Key Laboratory of Metabolic and Chronic Diseases, Wuhan 430060, China.
  • State Key Laboratory of Neurology and Oncology Drug Development, Nanjing 210000, China.

ORCID-Profile: Bo Shen

Förderung

  • Hubei Provincial Key Research and Development Program

Zitieren

APA

Liu, Y. X., Guo, F. M., Qiu, W. J., Gao, Y. P., Han, X. Y., & Shen, B. (2025). Metabolic Reprogramming and Cell Interaction in Atherosclerosis: From Molecular Mechanisms to Therapeutic Strategies. Journal of Cardiovascular Development and Disease, 12(10), 384. https://doi.org/10.3390/jcdd12100384

Vancouver

Liu YX, Guo FM, Qiu WJ, Gao YP, Han XY, Shen B. Metabolic Reprogramming and Cell Interaction in Atherosclerosis: From Molecular Mechanisms to Therapeutic Strategies. Journal of Cardiovascular Development and Disease. 2025;12(10):384. doi:10.3390/jcdd12100384

BibTeX
@article{Liu2025,
  author = {Liu, Yu-Xin and Guo, Feng-Ming and Qiu, Wen-Jun and Gao, Yi-Peng and Han, Xue-Yu and Shen, Bo},
  title = {Metabolic Reprogramming and Cell Interaction in Atherosclerosis: From Molecular Mechanisms to Therapeutic Strategies},
  journal = {Journal of Cardiovascular Development and Disease},
  year = {2025},
  volume = {12},
  number = {10},
  pages = {384},
  doi = {10.3390/jcdd12100384}
}
Kostenlos starten →